Yin Haipeng, Li He, Xu Jian, Wu Ju
Department of Hepatobiliary Surgery, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
J Gastrointest Oncol. 2023 Apr 29;14(2):886-899. doi: 10.21037/jgo-23-71. Epub 2023 Apr 26.
Right-sided colon cancers (R-CCs) are associated with worse outcomes compared to left-sided colon cancers (L-CCs). This study aimed to investigate whether a difference in survival existed among R-CC, L-CC, and rectal cancer (ReC) and subsequent liver metastasis.
Data from the Surveillance, Epidemiology, and End Results (SEER) database for 2010-2015 was used to identify colorectal cancer (CRC) patients who underwent surgical resection of primary disease. Propensity score adjustment and Cox regression models were used to identify risk factors and prognostic factors of primary tumor location (PTL). Kaplan-Meier curve analysis and the log-rank test were used to evaluate overall survival (OS) of CRC patients.
Our results showed that among the 73,350 included patients, 49% were R-CC, 27.6% L-CC, and 23.1% ReC. Before propensity score matching (PSM), the OS of the R-CC group was significantly lower than that of the L-CC and ReC groups (P<0.05). However, the clinicopathological characteristics, including gender, tumor grade, tumor size, marital status, tumor (T) stage, node (N) stage, and carcinoembryonic antigen (CEA), were significantly unbalanced among the 3 groups (P<0.05). After 1:1 PSM, 8670 patients were effectively screened out in each group. The differences in clinicopathological characteristics among the 3 groups were significantly reduced, and baseline distribution characteristics such as gender, tumor size, and CEA were significantly improved after matching (P>0.05). Survival was higher in the left-side group when evaluated by tumor sidedness, and ReC patients had the highest median survival (114.3 months). Right-sided cancer patients had the worst prognosis in both PTL and sidedness analyses, with a median survival of 76.6 months. Among CRC patients with synchronous liver metastases, adjustment by inverse propensity weight and propensity score and analysis of OS yielded similar results and had more significant stratification results.
In conclusion, R-CC has a worse survival prognosis compared to L-CC and ReC, and they are fundamentally different tumors that have distinct effects on CRC patients with liver metastases.
与左侧结肠癌(L-CC)相比,右侧结肠癌(R-CC)的预后较差。本研究旨在调查R-CC、L-CC和直肠癌(ReC)以及随后发生肝转移的患者在生存率上是否存在差异。
使用2010 - 2015年监测、流行病学和最终结果(SEER)数据库中的数据,以确定接受原发性疾病手术切除的结直肠癌(CRC)患者。采用倾向评分调整和Cox回归模型来确定原发性肿瘤位置(PTL)的危险因素和预后因素。采用Kaplan-Meier曲线分析和对数秩检验来评估CRC患者的总生存期(OS)。
我们的结果显示,在纳入的73350例患者中,49%为R-CC,27.6%为L-CC,23.1%为ReC。在倾向评分匹配(PSM)之前,R-CC组的OS显著低于L-CC组和ReC组(P<0.05)。然而,这3组患者的临床病理特征,包括性别、肿瘤分级、肿瘤大小、婚姻状况、肿瘤(T)分期、淋巴结(N)分期和癌胚抗原(CEA),存在显著不平衡(P<0.05)。经过1:1 PSM后,每组有效筛选出8670例患者。3组间临床病理特征的差异显著减小,匹配后性别、肿瘤大小和CEA等基线分布特征显著改善(P>0.05)。按肿瘤部位评估时,左侧组的生存率较高,ReC患者的中位生存期最高(114.3个月)。在PTL和部位分析中,右侧癌症患者的预后最差,中位生存期为76.6个月。在伴有同步肝转移的CRC患者中,采用逆倾向权重和倾向评分调整并分析OS得到了相似的结果,且分层结果更显著。
总之,与L-CC和ReC相比,R-CC的生存预后更差,它们是本质上不同的肿瘤,对伴有肝转移的CRC患者有不同的影响。